{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:26Z","timestamp":1787069006909,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00415-021-10536-3","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T06:03:18Z","timestamp":1616997798000},"page":"750-757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Opsoclonus\u2013myoclonus\u2013ataxia syndrome in children"],"prefix":"10.1007","volume":"269","author":[{"given":"Poonam","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-7891","authenticated-orcid":false,"given":"Michael C.","family":"Kruer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"issue":"8","key":"10536_CR1","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1212\/WNL.0000000000006035","volume":"91","author":"G Berridge","year":"2018","unstructured":"Berridge G, Menassa DA, Moloney T et al (2018) Glutamate receptor \u03b42 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology 91(8):e714\u2013e723","journal-title":"Neurology"},{"issue":"2","key":"10536_CR2","first-page":"156","volume":"14","author":"KK Pang","year":"2010","unstructured":"Pang KK, de Sousa C, Lang B, Pike MG, Pang KK et al (2010) A prospective study of the presentation and management of dancing eye syndrome\/opsoclonus-myoclonus syndrome in the United Kingdom. Eur J PaediatrNeurol 14(2):156\u2013161","journal-title":"Eur J PaediatrNeurol"},{"issue":"6\u20137","key":"10536_CR3","doi-asserted-by":"publisher","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","volume":"11","author":"U Nussinovitch","year":"2012","unstructured":"Nussinovitch U, Shoenfeld Y (2012) The role of gender and organ specific autoimmunity. Autoimmun Rev 11(6\u20137):A377\u2013A385","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10536_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/mpo.1138","volume":"36","author":"E Rudnick","year":"2001","unstructured":"Rudnick E, Khakoo Y, Antunes NL et al (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children\u2019s Cancer Group Study. Med Pediatr Oncol 36(6):612\u2013622","journal-title":"Med Pediatr Oncol"},{"key":"10536_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fneur.2017.00468","volume":"8","author":"MR Pranzatelli","year":"2017","unstructured":"Pranzatelli MR, Tate ED, McGee NR (2017) Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol 8:468","journal-title":"Front Neurol"},{"issue":"1\u20132","key":"10536_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","volume":"228","author":"KK Matthay","year":"2005","unstructured":"Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, Pike M, Matthay PV, KK, et al (2005) Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett 228(1\u20132):275\u2013282","journal-title":"Cancer Lett"},{"issue":"8","key":"10536_CR7","doi-asserted-by":"publisher","first-page":"e27097","DOI":"10.1002\/pbc.27097","volume":"65","author":"MR Pranzatelli","year":"2018","unstructured":"Pranzatelli MR, Tate ED, McGee NR (2018) Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (\u201cTumor\u201d vs \u201cNo tumor\u201d) in a cohort of 356 US children. Pediatr Blood Cancer 65(8):e27097","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10536_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jamaneurol.2013.4786","volume":"71","author":"MC Kruer","year":"2014","unstructured":"Kruer MC, Hoeftberger R, Lim KY et al (2014) Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of \u03b3-aminobutyric acid type B receptor autoimmunity. JAMA Neurol 71(5):620\u2013623","journal-title":"JAMA Neurol"},{"issue":"12","key":"10536_CR9","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s00415-012-6545-z","volume":"259","author":"L Blumkin","year":"2012","unstructured":"Blumkin L, Kivity S, Lev D et al (2012) A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J Neurol 259(12):2590\u20132598","journal-title":"J Neurol"},{"issue":"19","key":"10536_CR10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJM200405063501922","volume":"350","author":"Y Tsubono","year":"2004","unstructured":"Tsubono Y, Hisamichi S (2004) A halt to neuroblastoma screening in Japan. N Engl J Med 350(19):2010\u20132011","journal-title":"N Engl J Med"},{"issue":"5","key":"10536_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/adc.2010.204792","volume":"97","author":"A Brunklaus","year":"2012","unstructured":"Brunklaus A, Pohl K, Zuberi SM, de Sousa C (2012) Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome. Arch Dis Child 97(5):461\u2013463","journal-title":"Arch Dis Child"},{"issue":"12","key":"10536_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/08830738040190120201","volume":"19","author":"MR Pranzatelli","year":"2004","unstructured":"Pranzatelli MR, Hyland K, Tate ED, Arnold LA, Allison TJ, Soori GS (2004) Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin. J Child Neurol 19(12):919\u2013924","journal-title":"J Child Neurol"},{"issue":"1","key":"10536_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","volume":"45","author":"MR Pranzatelli","year":"2011","unstructured":"Pranzatelli MR, Slev PR, Tate ED, Travelstead AL, Colliver JA, Joseph SA (2011) Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus. Pediatr Neurol 45(1):27\u201333","journal-title":"Pediatr Neurol"},{"key":"10536_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2015.07.007","volume":"286","author":"JA Panzer","year":"2015","unstructured":"Panzer JA, Anand R, Dalmau J, Lynch DR (2015) Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. J Neuroimmunol 286:86\u201392","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10536_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mds.20125","volume":"19","author":"MR Pranzatelli","year":"2004","unstructured":"Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ (2004) CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord 19(7):770\u2013777","journal-title":"Mov Disord"},{"issue":"9","key":"10536_CR16","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","volume":"62","author":"MR Pranzatelli","year":"2004","unstructured":"Pranzatelli MR, Travelstead AL, Tate ED et al (2004) B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62(9):1526\u20131532","journal-title":"Neurology"},{"issue":"1","key":"10536_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.braindev.2019.08.003","volume":"42","author":"K Takeda","year":"2020","unstructured":"Takeda K, Miyamoto Y, Yamamoto H, Ishii A, Hirose S, Yamamoto H (2020) Clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation. Brain Dev 42(1):73\u201376","journal-title":"Brain Dev"},{"issue":"6","key":"10536_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ejpn.2015.07.010","volume":"19","author":"B Drivenes","year":"2015","unstructured":"Drivenes B, Born AP, Ek J, Dunoe M, Uldall PV (2015) A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome. Eur J Paediatr Neurol 19(6):719\u2013721","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10536_CR19","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1542\/peds.2010-3114","volume":"128","author":"A Brunklaus","year":"2011","unstructured":"Brunklaus A, Pohl K, Zuberi SM, de Sousa C (2011) Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics 128(2):e388\u2013e394","journal-title":"Pediatrics"},{"key":"10536_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/B978-0-444-52910-7.00042-8","volume":"112","author":"M Pike","year":"2013","unstructured":"Pike M (2013) Opsoclonus-myoclonus syndrome. Handb Clin Neurol 112:1209\u20131211","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10536_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X,PMID29376112","volume":"2","author":"PA de Alarcon","year":"2018","unstructured":"de Alarcon PA, Matthay KK, London WB et al (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health 2(1):25\u201334. https:\/\/doi.org\/10.1016\/S2352-4642(17)30130-X,PMID29376112","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"10536_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.braindev.2015.11.007","volume":"38","author":"MR Pranzatelli","year":"2016","unstructured":"Pranzatelli MR, Tate ED (2016) Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome. Brain Dev 38(5):439\u2013448","journal-title":"Brain Dev"},{"issue":"8","key":"10536_CR23","doi-asserted-by":"publisher","first-page":"e27776","DOI":"10.1002\/pbc.27776","volume":"66","author":"C Wilbur","year":"2019","unstructured":"Wilbur C, Yea C, Licht C, Irwin MS, Yeh EA (2019) An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome. Pediatr Blood Cancer 66(8):e27776","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10536_CR24","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/dmcn.14628","volume":"62","author":"A Sheridan","year":"2020","unstructured":"Sheridan A, Kapur K, Pinard F, Dietrich Alber F, Camposano S, Pike MG, Klein A, Gorman MP (2020) IQ predictors in pediatric opsoclonus myoclonus syndrome: a large international cohort study. Dev Med Child Neurol 62(12):1444\u20131449. https:\/\/doi.org\/10.1111\/dmcn.14628","journal-title":"Dev Med Child Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10536-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:13:35Z","timestamp":1642760015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10536-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10536"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10536-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MCK serves as a consultant for the United States Health Research Services Administration. The remaining authors report no conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}